Middle East Liquid Biopsy Market - By Technology ; By Work Flow ; By Usage ; By Sample ; By Circulating Biomarker ; By Product, Trend Analysis, Competitive Landscape & Forecast, 2019-2029

List of Tables

Middle East Liquid Biopsy Market Size More Than Doubles to Cross USD 108 billion by 2029.

Middle East liquid biopsy market is flourishing owing to rising awareness of the availability of various non-invasive treatments and rising cancer prevalence rates worldwide.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimates Middle East liquid biopsy market size at USD 47.6 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects Middle East liquid biopsy market size to grow at a significant CAGR of 12.9% reaching a value of USD 108.5 billion by 2029. Rising awareness of the availability of various non-invasive treatments as well as the prevalence of cancer are key factors propelling the market's expansion. Due to the rising prevalence of the disease among women, breast cancer is now the most common type of cancer diagnosed globally. Quick results, low cost, early prognosis, overcoming tumor heterogeneity, low risk, and non-invasiveness are just a few benefits of the new liquid biopsy technique. All these benefits over traditional diagnosis are driving the adoption of liquid biopsy among patients throughout the Global Middle East, and it is expected that this will lead to a significant increase in demand during the forecast period.

Middle East Liquid Biopsy Market - Overview

A liquid biopsy is a procedure that analyzes a sample of living tissue while it is still liquid to detect and track the development of diseases like cancer. Human genome sequencing and increased sensitivity of detection methods and assays are two developments in medical science that liquid biopsy directly makes use of. There is no post-operative discomfort with liquid biopsies because the painful tissue sample extraction is not required. For instance, blood and urine, which can both be collected easily and with little discomfort, make up most of the liquid samples used in the method. However, some situations call for difficult procedures, such as spinal fluid. Thus, liquid biopsy aids patients in experiencing less anxiety brought on by pain. Furthermore, it gives patients who are unable to undergo a tissue biopsy due to the risks involved-such as those with lung cancer whose tumors are too dangerously close to the heart-a safe and efficient alternative.

Opportunity: Government investments in healthcare infrastructure

The increased funding from the federal government is expected to drive the market's growth rate. The market will benefit from the high return on investment guaranteed by research activities. Increased personal disposable income, the introduction of technologically driven products in hospitals, increased investment in the development of advanced medical products and devices, and an increase in demand for non-invasive surgical procedures all have a positive impact on the market growth rate.

Challenge:

Positive and false negative outcomes

Market expansion is expected to be hampered by high R&D costs, a lack of infrastructure, and the lower sensitivity of some liquid biopsies. During the forecast period of 2022-2029, challenges to the market are also expected to include a lack of favorable reimbursement scenarios and technology penetration in developing economies, the requirement for sizable capital investments to establish production facilities, the low sensitivity and specificity limitations of liquid biopsy, and a lack of suitable infrastructure in low- and middle-income countries.

Impact of COVID-19 on Middle East Liquid Biopsy Market

Market expansion and revenue were significantly impacted by the COVID-19 pandemic. The evaluation of the current market considered data from key industry players on both the supply and demand sides. Although low-scale losses were incurred by manufacturers because of the decline in demand, the losses were offset by increased demand in the following two quarters of FY2021. However, between 2020 and 2022, the industry is still anticipated to be significantly impacted. The Cologuard test sales at Exact Sciences have been significantly impacted by the low number of cancer patients in hospitals and diagnostic labs.

Middle East Liquid Biopsy Market - By Technology

Middle East liquid biopsy market is segmented into Fluorescence In-Situ Hybridization (FISH), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Technologies. The Multi-gene-parallel Analysis (NGS) segment currently dominates the Middle East liquid biopsy market in terms of revenue, and it is expected that it will do so for the duration of the forecast. Both potential resistance mechanisms that might have developed from pre-existing clones after therapy and a wide variety of mutations that might contribute to tumorigenesis can be found using NGS technology. High-accuracy sequencing now costs significantly less due to recent rapid advancements in NGS technology. With the aid of targeted panels, this technology allows for the accurate and sensitive detection of ctDNA mutations as well as the screening of unidentified variants.

Competitive Landscape:

Middle East liquid biopsy market is fiercely competitive. Prominent players include: Bio-Rad Laboratories, Inc., Bioscience Institute S.p.A., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Guardant Health, Illumina, Inc., Natera, Inc., NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Middle East liquid biopsy market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Middle East Liquid Biopsy Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Middle East Liquid Biopsy Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC23008

1. Research Framework

1.1. Research Objective
1.2. Liquid Biopsy Overview
1.3. Market Segmentation

2. Executive Summary

3. Middle East Liquid Biopsy Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Demand for Liquid Biopsies Rises Due to Increased Cancer Rate
  - 3.2.1.2. Patients Are Increasingly Favoring Non-Invasive Cancer Diagnosis
  - 3.2.1.3. Possibilities for Liquid Biopsy
- 3.2.2. Restraints
  - 3.2.2.1. Positives and False Negatives Results
- 3.2.3. Opportunities
  - 3.2.3.1. Non-Invasive Liquid Biopsy and Artificial Intelligence (AI) Combined
- 3.2.4. Challenge
3.3. Recent Developments/Technological Advancement
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Middle East Liquid Biopsy Market Overview

4.1. Market Size & Forecast, 2019-2029
- 4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
- 4.2.1. By Technology
  - 4.2.1.1. Polymerase Chain Reaction (PCR)
  - 4.2.1.2. Next-Generation Sequencing (NGS)
  - 4.2.1.3. Fluorescence In-Situ Hybridization (FISH)
  - 4.2.1.4. Other Technologies
- 4.2.2. By Workflow
  - 4.2.2.1. Sample Preparation
  - 4.2.2.2. Library Preparation
  - 4.2.2.3. Sequencing
  - 4.2.2.4. Data Analysis
- 4.2.3. By Usage
  - 4.2.3.1. Research Use Only (RUO)
  - 4.2.3.2. Clinical
- 4.2.4. By Sample
  - 4.2.4.1. Blood
  - 4.2.4.2. Urine
  - 4.2.4.3. Saliva
- 4.2.5. By Circulating Biomarker
  - 4.2.5.1. Circulating Tumor Cells (CTCs)
  - 4.2.5.2. Cell-Free DNA (cfDNA)
  - 4.2.5.3. Circulating Cell-Free RNA
  - 4.2.5.4. Exosomes and Extracellular Vesicles
  - 4.2.5.5. Other Circulating Biomarkers
- 4.2.6. By Product
  - 4.2.6.1. Tests/Services
  - 4.2.6.2. Kits and Consumables
  - 4.2.6.3. Instruments

5. Middle East & Africa Middle East Liquid Biopsy Market

5.1. Market Size & Forecast, 2019-2029
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Technology
- 5.2.2. By Workflow
- 5.2.3. By Usage
- 5.2.4. By Sample
- 5.2.5. By Circulating Biomarker
- 5.2.6. By Product
- 5.2.7. By Country
  - 5.2.7.1. Saudi Arabia
  - 5.2.7.1.1. By Technology
  - 5.2.7.1.2. By Workflow
  - 5.2.7.1.3. By Usage
  - 5.2.7.1.4. By Sample
  - 5.2.7.1.5. By Circulating Biomarker
  - 5.2.7.1.6. By Product
  - 5.2.7.2. UAE
  - 5.2.7.2.1. By Technology
  - 5.2.7.2.2. By Workflow
  - 5.2.7.2.3. By Usage
  - 5.2.7.2.4. By Sample
  - 5.2.7.2.5. By Circulating Biomarker
  - 5.2.7.2.6. By Product
  - 5.2.7.3. Qatar
  - 5.2.7.3.1. By Technology
  - 5.2.7.3.2. By Workflow
  - 5.2.7.3.3. By Usage
  - 5.2.7.3.4. By Sample
  - 5.2.7.3.5. By Circulating Biomarker
  - 5.2.7.3.6. By Product
  - 5.2.7.4. Kuwait
  - 5.2.7.4.1. By Technology
  - 5.2.7.4.2. By Workflow
  - 5.2.7.4.3. By Usage
  - 5.2.7.4.4. By Sample
  - 5.2.7.4.5. By Circulating Biomarker
  - 5.2.7.4.6. By Product
  - 5.2.7.5. South Africa
  - 5.2.7.5.1. By Technology
  - 5.2.7.5.2. By Workflow
  - 5.2.7.5.3. By Usage
  - 5.2.7.5.4. By Sample
  - 5.2.7.5.5. By Circulating Biomarker
  - 5.2.7.5.6. By Product
  - 5.2.7.6. Nigeria
  - 5.2.7.6.1. By Technology
  - 5.2.7.6.2. By Workflow
  - 5.2.7.6.3. By Usage
  - 5.2.7.6.4. By Sample
  - 5.2.7.6.5. By Circulating Biomarker
  - 5.2.7.6.6. By Product
  - 5.2.7.7. Egypt
  - 5.2.7.7.1. By Technology
  - 5.2.7.7.2. By Workflow
  - 5.2.7.7.3. By Usage
  - 5.2.7.7.4. By Sample
  - 5.2.7.7.5. By Circulating Biomarker
  - 5.2.7.7.6. By Product
  - 5.2.7.8. Rest of Middle East & Africa
  - 5.2.7.8.1. By Technology
  - 5.2.7.8.2. By Workflow
  - 5.2.7.8.3. By Usage
  - 5.2.7.8.4. By Sample
  - 5.2.7.8.5. By Circulating Biomarker
  - 5.2.7.8.6. By Product

6. Competitive Landscape

6.1. List of Key Players and Their Offerings
6.2. Middle East Liquid Biopsy Company Market Share Analysis, 2022
6.3. Competitive Benchmarking, By Operating Parameters
6.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

7. Impact of Covid-19 on Global Middle East Liquid Biopsy Market

8. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

8.1. Bio-Rad Laboratories, Inc.
8.2. Bioscience Institute S.p.A.
8.3. Eurofins Scientific
8.4. F. Hoffmann-La Roche Ltd
8.5. Guardant Health
8.6. Illumina, Inc.
8.7. Natera, Inc.
8.8. NeoGenomics Laboratories, Inc.
8.9. PerkinElmer Inc.
8.10. QIAGEN N.V.
8.11. Sysmex Corporation
8.12. Thermo Fisher Scientific Inc
8.13. Other Prominent Players

9. Key Strategic Recommendations

10. Research Methodology

10.1. Qualitative Research
- 10.1.1. Primary & Secondary Research
10.2. Quantitative Research
10.3. Market Breakdown & Data Triangulation
- 10.3.1. Secondary Research
- 10.3.2. Primary Research
10.4. Breakdown of Primary Research Respondents, By Region
10.5. Assumptions & Limitations

*Financial information in case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

Product Code: BWC23008

List of Figures

Figure 1 Middle East & Africa Liquid Biopsy Segmentation
Figure 2 Middle East & Africa Liquid Biopsy Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2021
Figure 4 Middle East & Africa Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 5 Middle East & Africa Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 6 Middle East & Africa Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 7 Middle East & Africa Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 8 Middle East & Africa Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 9 Middle East & Africa Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 10 Middle East & Africa Liquid Biopsy Market Share, By Product, By Value, 2019-2029
Figure 11 Middle East & Africa Liquid Biopsy Market Share, By Country, By Value, 2019-2029
Figure 12 Saudi Arabia Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 13 Saudi Arabia Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 14 Saudi Arabia Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 15 Saudi Arabia Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 16 Saudi Arabia Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 17 Saudi Arabia Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 18 Saudi Arabia Liquid Biopsy Market Share, By Product, By Value, 2019-2029
Figure 19 UAE Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 20 UAE Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 21 UAE Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 22 UAE Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 23 UAE Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 24 UAE Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 25 UAE Liquid Biopsy Market Share, By Product, By Value, 2019-2029
Figure 26 Qatar Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 27 Qatar Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 28 Qatar Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 29 Qatar Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 30 Qatar Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 31 Qatar Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 32 Qatar Liquid Biopsy Market Share, By Product, By Value, 2019-2029
Figure 33 Kuwait Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 34 Kuwait Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 35 Kuwait Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 36 Kuwait Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 37 Kuwait Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 38 Kuwait Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 39 Kuwait Liquid Biopsy Market Share, By Product, By Value, 2019-2029
Figure 40 South Africa Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 41 South Africa Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 42 South Africa Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 43 South Africa Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 44 South Africa Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 45 South Africa Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 46 South Africa Liquid Biopsy Market Share, By Product, By Value, 2019-2029
Figure 47 Nigeria Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 48 Nigeria Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 49 Nigeria Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 50 Nigeria Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 51 Nigeria Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 52 Nigeria Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 53 Nigeria Liquid Biopsy Market Share, By Product, By Value, 2019-2029
Figure 54 Egypt Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 55 Egypt Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 56 Egypt Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 57 Egypt Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 58 Egypt Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 59 Egypt Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 60 Egypt Liquid Biopsy Market Share, By Product, By Value, 2019-2029
Figure 61 Rest of Middle East & Africa Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Figure 62 Rest of Middle East & Africa Liquid Biopsy Market Share, By Technology, By Value, 2019-2029
Figure 63 Rest of Middle East & Africa Liquid Biopsy Market Share, By Workflow, By Value, 2019-2029
Figure 64 Rest of Middle East & Africa Liquid Biopsy Market Share, By Usage, By Value, 2019-2029
Figure 65 Rest of Middle East & Africa Liquid Biopsy Market Share, By Sample, By Value, 2019-2029
Figure 66 Rest of Middle East & Africa Liquid Biopsy Market Share, By Circulating Biomarker, By Value, 2019-2029
Figure 67 Rest of Middle East & Africa Liquid Biopsy Market Share, By Product, By Value, 2019-2029

List of Tables

Table 1 Middle East & Africa Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 2 Middle East & Africa Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 3 Middle East & Africa Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 4 Middle East & Africa Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 5 Middle East & Africa Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 6 Middle East & Africa Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 7 Middle East & Africa Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 8 Middle East & Africa Liquid Biopsy Market Size, By Country, By Value, 2019-2029
Table 9 Saudi Arabia Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 10 Saudi Arabia Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 11 Saudi Arabia Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 12 Saudi Arabia Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 13 Saudi Arabia Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 14 Saudi Arabia Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 15 Saudi Arabia Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 16 UAE Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 17 UAE Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 18 UAE Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 19 UAE Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 20 UAE Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 21 UAE Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 22 UAE Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 23 Qatar Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 24 Qatar Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 25 Qatar Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 26 Qatar Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 27 Qatar Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 28 Qatar Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 29 Qatar Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 30 Kuwait Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 31 Kuwait Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 32 Kuwait Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 33 Kuwait Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 34 Kuwait Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 35 Kuwait Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 36 Kuwait Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 37 South Africa Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 38 South Africa Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 39 South Africa Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 40 South Africa Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 41 South Africa Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 42 South Africa Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 43 South Africa Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 44 Nigeria Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 45 Nigeria Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 46 Nigeria Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 47 Nigeria Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 48 Nigeria Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 49 Nigeria Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 50 Nigeria Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 51 Egypt Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 52 Egypt Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 53 Egypt Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 54 Egypt Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 55 Egypt Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 56 Egypt Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 57 Egypt Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 58 Rest of Middle East & Africa Liquid Biopsy Market Size, By Value (USD Million), 2019-2029
Table 59 Rest of Middle East & Africa Liquid Biopsy Market Size, By Technology, By Value, 2019-2029
Table 60 Rest of Middle East & Africa Liquid Biopsy Market Size, By Workflow, By Value, 2019-2029
Table 61 Rest of Middle East & Africa Liquid Biopsy Market Size, By Usage, By Value, 2019-2029
Table 62 Rest of Middle East & Africa Liquid Biopsy Market Size, By Sample, By Value, 2019-2029
Table 63 Rest of Middle East & Africa Liquid Biopsy Market Size, By Circulating Biomarker, By Value, 2019-2029
Table 64 Rest of Middle East & Africa Liquid Biopsy Market Size, By Product, By Value, 2019-2029
Table 65 Bio-Rad Laboratories, Inc. Company Overview
Table 66 Bio-Rad Laboratories, Inc. Financial Overview
Table 67 Bioscience Institute S.p.A. Company Overview
Table 68 Bioscience Institute S.p.A. Financial Overview
Table 69 Eurofins Scientific Technologies Co., Ltd. Company Overview
Table 70 Eurofins Scientific Technologies Co., Ltd. Financial Overview
Table 71 F. Hoffmann-La Roche Ltd Company Overview
Table 72 F. Hoffmann-La Roche Ltd Financial Overview
Table 73 Guardant Health Company Overview
Table 74 Guardant Health Financial Overview
Table 75 Illumina, Inc. Company Overview
Table 76 Illumina, Inc. Financial Overview
Table 77 Natera, Inc. Company Overview
Table 78 Natera, Inc. Financial Overview
Table 79 NeoGenomics Laboratories, Inc. Company Overview
Table 80 NeoGenomics Laboratories, Inc. Financial Overview
Table 81 PerkinElmer Inc. Company Overview
Table 82 PerkinElmer Inc. Financial Overview
Table 83 QIAGEN N.V. Company Overview
Table 84 QIAGEN N.V. Financial Overview
Table 85 Sysmex Corporation Company Overview
Table 86 Sysmex Corporation Financial Overview

Middle East Liquid Biopsy Market - By Technology ; By Work Flow ; By Usage ; By Sample ; By Circulating Biomarker ; By Product, Trend Analysis, Competitive Landscape & Forecast, 2019-2029

Description

Table of Contents

List of Tables

Middle East Liquid Biopsy Market Size More Than Doubles to Cross USD 108 billion by 2029.

Middle East Liquid Biopsy Market - Overview

Opportunity: Government investments in healthcare infrastructure

Challenge:

Positive and false negative outcomes

Impact of COVID-19 on Middle East Liquid Biopsy Market

Middle East Liquid Biopsy Market - By Technology

Competitive Landscape:

Table of Contents

1. Research Framework

2. Executive Summary

3. Middle East Liquid Biopsy Market Insights

4. Middle East Liquid Biopsy Market Overview

5. Middle East & Africa Middle East Liquid Biopsy Market

6. Competitive Landscape

7. Impact of Covid-19 on Global Middle East Liquid Biopsy Market

8. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

9. Key Strategic Recommendations

10. Research Methodology

List of Figures

List of Tables